JP2021520809A - がんまたは新生物評価のための組成物および方法 - Google Patents

がんまたは新生物評価のための組成物および方法 Download PDF

Info

Publication number
JP2021520809A
JP2021520809A JP2020555453A JP2020555453A JP2021520809A JP 2021520809 A JP2021520809 A JP 2021520809A JP 2020555453 A JP2020555453 A JP 2020555453A JP 2020555453 A JP2020555453 A JP 2020555453A JP 2021520809 A JP2021520809 A JP 2021520809A
Authority
JP
Japan
Prior art keywords
target
methylation
kit
sequencing
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020555453A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019199696A5 (https=
JP2021520809A5 (https=
Inventor
アサーヴァ ジェイ． ゴア，
アサーヴァ ジェイ． ゴア，
ジェフリー エー． ゴール，
ジェフリー エー． ゴール，
ルイ リウ，
ルイ リウ，
Original Assignee
シングレラ ジェノミクス， インコーポレイテッド
シングレラ ジェノミクス， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by シングレラ ジェノミクス， インコーポレイテッド, シングレラ ジェノミクス， インコーポレイテッド filed Critical シングレラ ジェノミクス， インコーポレイテッド
Publication of JP2021520809A publication Critical patent/JP2021520809A/ja
Publication of JPWO2019199696A5 publication Critical patent/JPWO2019199696A5/ja
Publication of JP2021520809A5 publication Critical patent/JP2021520809A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2531/00—Reactions of nucleic acids characterised by
    • C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
    • C12Q2531/113—PCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2020555453A 2018-04-12 2019-04-08 がんまたは新生物評価のための組成物および方法 Pending JP2021520809A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862656820P 2018-04-12 2018-04-12
US62/656,820 2018-04-12
PCT/US2019/026395 WO2019199696A1 (en) 2018-04-12 2019-04-08 Compositions and methods for cancer or neoplasia assessment

Publications (3)

Publication Number Publication Date
JP2021520809A true JP2021520809A (ja) 2021-08-26
JPWO2019199696A5 JPWO2019199696A5 (https=) 2022-04-15
JP2021520809A5 JP2021520809A5 (https=) 2022-04-15

Family

ID=68163272

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020555453A Pending JP2021520809A (ja) 2018-04-12 2019-04-08 がんまたは新生物評価のための組成物および方法

Country Status (10)

Country Link
US (1) US20210388445A1 (https=)
EP (1) EP3775290A4 (https=)
JP (1) JP2021520809A (https=)
KR (1) KR20210003795A (https=)
CN (1) CN112352057A (https=)
AU (1) AU2019253569A1 (https=)
CA (1) CA3096668A1 (https=)
SG (1) SG11202009866XA (https=)
TW (1) TW202012638A (https=)
WO (1) WO2019199696A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111989407B (zh) 2018-03-13 2024-10-29 格里尔公司 异常的片段检测及分类
CN119753091A (zh) 2018-04-02 2025-04-04 格里尔公司 用于扩增与癌症相关联的cfDNA分子的化验板
IL281741B2 (en) 2018-09-27 2026-04-01 Grail Inc Methylation markers and a targeted methylation detection panel
WO2020132572A1 (en) 2018-12-21 2020-06-25 Grail, Inc. Source of origin deconvolution based on methylation fragments in cell-free-dna samples
US12584177B2 (en) 2019-01-24 2026-03-24 Mayo Foundation For Medical Education And Research Detecting endometrial cancer
US11795495B1 (en) * 2019-10-02 2023-10-24 FOXO Labs Inc. Machine learned epigenetic status estimator
CA3154354A1 (en) * 2019-10-31 2021-05-06 William R. Taylor Detecting ovarian cancer
CN111833965B (zh) * 2019-11-08 2024-06-04 中国科学院北京基因组研究所(国家生物信息中心) 一种尿沉渣基因组dna的分类方法、装置和用途
US20230002832A1 (en) * 2019-11-27 2023-01-05 Keio University Upper urinary tract urothelial carcinoma identification method
IL296453A (en) * 2020-03-20 2022-11-01 Singlera Health Tech Shanghai Ltd Methods and kits for screening colorectal neoplasm
EP4419714A4 (en) * 2021-11-23 2025-02-26 Pleno, Inc. CODED DOSAGES
CN118451202A (zh) * 2021-12-20 2024-08-06 江苏鹍远生物技术有限公司 一种肿瘤检测方法及应用
CN114959038B (zh) * 2022-06-13 2024-12-17 湖南宏雅基因技术有限公司 一种hoxa9基因甲基化检测试剂及其应用
CN117766028B (zh) * 2022-09-16 2025-03-11 深圳吉因加医学检验实验室 一种基于甲基化差异预测样本来源的方法及装置
WO2024117791A1 (ko) 2022-11-29 2024-06-06 주식회사 지씨지놈 식도암 및 위암 진단용 dna 메틸화 마커 및 이의 용도
WO2024137858A2 (en) * 2022-12-22 2024-06-27 Singlera Genomics Inc. Methods and compositions for assessing colorectal cancer
EP4669776A1 (en) * 2023-02-22 2025-12-31 University of Southern California EARLY PAN-CANCER DETECTION AND CFDNA METHYLATION IN THE CONTEXT OF MINIMAL RESIDUAL DISEASE
WO2025203031A2 (en) * 2024-03-26 2025-10-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Methods of cancer detection by discordant methylation in cfdna

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170283887A1 (en) * 2014-11-25 2017-10-05 Ait Austrian Institute Of Technology Gmbh Diagnosis of lung cancer

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1942197A1 (de) * 2000-09-01 2008-07-09 Epigenomics AG Verfahren zur Bestimmung des Methylierungsgrades von bestimmten Cytosinen in genomischer DNA im Sequenzkontext 5'-CpG-3'
CN104846092A (zh) * 2007-02-21 2015-08-19 奥斯陆大学医院Hf 新型癌症标记物
US20100297067A1 (en) * 2007-05-14 2010-11-25 The Johns Hopkins University Methylation markers for prostate cancer and methods of use
US7843254B2 (en) * 2007-10-31 2010-11-30 Texas Instruments Incorporated Methods and apparatus to produce fully isolated NPN-based bandgap reference
WO2009108917A2 (en) * 2008-02-29 2009-09-03 Oncomethylome Sciences, S.A. Markers for improved detection of breast cancer
US20110223180A1 (en) * 2010-03-11 2011-09-15 Aldape Kenneth D Methods and compositions related to a multi-methylation assay to predict patient outcome
AU2013262435B2 (en) * 2012-05-18 2019-03-07 Clinical Genomics Pty. Ltd. A method of screening for colorectal cancer
CN105339507A (zh) * 2013-02-21 2016-02-17 托马生物科学公司 用于核酸分析的方法、组合物和试剂盒
EP2886659A1 (en) * 2013-12-20 2015-06-24 AIT Austrian Institute of Technology GmbH Gene methylation based colorectal cancer diagnosis
US9984201B2 (en) * 2015-01-18 2018-05-29 Youhealth Biotech, Limited Method and system for determining cancer status
WO2016138105A2 (en) * 2015-02-24 2016-09-01 Zymo Research Corporation Assays to determine dna methylation and dna methylation markers of cancer
EP3350344A1 (en) * 2015-09-17 2018-07-25 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Cancer detection methods
CN116064796A (zh) * 2016-05-05 2023-05-05 精密科学公司 通过分析甲基化dna来检测肺肿瘤

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170283887A1 (en) * 2014-11-25 2017-10-05 Ait Austrian Institute Of Technology Gmbh Diagnosis of lung cancer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GENE, 1997, VOL. 191,NO. 1, PP. 69-79, JPN6023017545, ISSN: 0005188733 *

Also Published As

Publication number Publication date
CN112352057A (zh) 2021-02-09
SG11202009866XA (en) 2020-11-27
US20210388445A1 (en) 2021-12-16
EP3775290A1 (en) 2021-02-17
CA3096668A1 (en) 2019-10-17
TW202012638A (zh) 2020-04-01
EP3775290A4 (en) 2021-12-29
WO2019199696A1 (en) 2019-10-17
KR20210003795A (ko) 2021-01-12
AU2019253569A1 (en) 2020-10-29

Similar Documents

Publication Publication Date Title
JP2021520809A (ja) がんまたは新生物評価のための組成物および方法
JP7220200B2 (ja) ライブラリー構築および配列解析のための組成物および方法
CN113661249B (zh) 用于分离无细胞dna的组合物和方法
US11214798B2 (en) Methods and compositions for rapid nucleic acid library preparation
EP3737774B1 (en) Method for analyzing nucleic acid
AU2014248511B2 (en) Systems and methods for prenatal genetic analysis
EP2619329B1 (en) Direct capture, amplification and sequencing of target dna using immobilized primers
US20200048697A1 (en) Compositions and methods for detection of genomic variance and DNA methylation status
CN110536967A (zh) 用于分析相联系核酸的试剂和方法
US10465241B2 (en) High resolution STR analysis using next generation sequencing
US20100273164A1 (en) Targeted and Whole-Genome Technologies to Profile DNA Cytosine Methylation
JP2024529674A (ja) 同時での変異検出およびメチル化分析のための方法
WO2024137858A2 (en) Methods and compositions for assessing colorectal cancer
WO2025178881A1 (en) Methods and compositions for assessing tissue and organ damage
HK40041271A (en) Compositions and methods for cancer or neoplasia assessment
HK1227442A1 (en) Methods and processes for non-invasive assessment of genetic variations
HK1227442B (en) Methods and processes for non-invasive assessment of genetic variations

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210203

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220407

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220407

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230501

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230724

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231002

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20231102

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240124

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240322

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240502

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20240502

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20240723